Macrophage Bridging Conduit Trafficking of HIV-1 Through the Endoplasmic Reticulum and Golgi Network by Kadiu, Irena & Gendelman, Howard E.
Published: May 12, 2011
r2011 American Chemical Society 3225 dx.doi.org/10.1021/pr200262q|J. Proteome Res. 2011, 10, 3225–3238
ARTICLE
pubs.acs.org/jpr
Macrophage Bridging Conduit Trafficking of HIV-1 Through the
Endoplasmic Reticulum and Golgi Network
Irena Kadiu
†,* and Howard E. Gendelman
†,‡,*
†Department of Pharmacologyand Experimental Neuroscience and
‡Department of Internal Medicine, University of Nebraska Medical
Center, Omaha, Nebraska 68198-5800, United States
b S Supporting Information
’INTRODUCTION
Bridging conduits (BC) also termed thick tunneling nano-
tubes (TNT) are cellular processes that sustain long distance
intercellular transport of RNA, organelles, and receptors.
1 4
In immunocytes, they enable antigen presentation and pro-
inﬂammatory immune responses.
5 Supported by both actin
ﬁlament and microtubules, macrophage BC extend >100 μmi n
length (our unpublished observations).
1 Viruses, prions and
bacteria may utilize the conduits to escape immune surveillance
and as such accelerate infection.
1,6,7 For the human immunode-
ﬁciency virus type 1 (HIV-1), such activities likely occur in
mononuclear phagocytes (MP, monocytes, macrophages, den-
driticcells)andCD4þTlymphocytesandaretargets,reservoirs,
andvehiclesformicrobialdissemination.
8,9Thevirusisknownto
modulate chemotactic communication and cell cell interac-
tions. The latter includes BC-mediated antigen presentation to
accelerate infection.
5,10 Indeed, direct cell-to-cell HIV-1 disse-
mination occurs 1000  faster than cell-free viral entry. This can
occur through the abilities of HIV-1 to bypass the rate-limiting
step of receptor-mediated fusion shielding it from humoral and
adoptive immune surveillance.
6
The underlying mechanisms of HIV-1 intercellular transfer
through conduits remained unknown as the process is complex
and seemingly convoluted. First, HIV-1 enters cells through
receptor-mediated endocytosis through clathrin-coated pits
followed by fusion with endosomal intermediates where virus
uncoating and content mixing can occur.
11 Second, downstream
fusion of clathrin-coated endosomes with a surface-accessible
tubular network of the early endosome results in the accumula-
tion of viral particulates in speciﬁc intracellular compartments.
12
In this manner, tubular endosome networks serve as intermedi-
ate station for downstream sorting of HIV-1 from early endo-
somes into multivesicular bodies (MVB) and Rab9 late endo-
somes where virus can remain infectious for extended time
periods.
13,14 Third, late endosomes can be further targeted to
the Trans-Golgi network which functions as a sorting “hub”
shuttling proteins to the plasma membrane.
15 Sorting of HIV-1
from endosomes to the ER and Golgi can then only allow
completion of viral life cycle.
16 18 Fourth, during productive
infection HIV-1 constituents are shuttled to Golgi and ER and
assemble into mature virions employing ER membranes, Golgi
and post-Golgi stacks and vesicles.
19,20 Lastly, prior to HIV-1
intercellular transfer through the bridging conduits (our unpub-
lished observations).
In the present work we elucidated endocytic traﬃcking path-
ways thateﬀectHIV-1BCtransport.HIV-1 endocytic traﬃcking
through ER and Golgi networks was found necessary for HIV-1
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cell-to-cell transfer. Indeed, characterization of the proteome
of isolated conduits revealed that these structures are highly
enriched with endosome populations involved in HIV-1 endo-
cytic entry andintracellular sorting totheERandGolgi.Imaging
showed a distribution of ﬂuorescently labeled HIV-1, HIV-1
envelope
þ (Env, gp120, gp160) and Gag
þ (Pr55, matrix, p24)
withtheseendocyticcompartmentsandER-Golgi.Disruptionof
endocytic transport from endosomes (early and late) to the ER-
Golgi impaired HIV-1 intercellular transfer. These observations,
taken together, provide new insights into intracellular viral
processing routes that drive HIV-1 spread through BC serv-
ing as a potential mechanism for evasion of host immune
surveillance.
’MATERIALS AND METHODS
Antibodies and Reagents
Rabbit Ab giantin, TGN38, Rab9, and mouse Ab to calnexin
were purchased from Cell Signaling Technologies. Human and
mouse Abs to HIV-1 components including those to Gag
(Gag
Pr55,p24,p17,matrix),gp120,gp160wereobtainedthrough
the NIH AIDS Research and Reference Reagent Program,
Division of AIDS, NIAID, NIH (Bethesda, MD). Rabbit Ab to
alpha and beta tubulin were purchased from Novus Biologicals.
Chicken antirabbit, goat antimouse Alexa 488, 594, 647, donkey
antisheepAlexa488,choleratoxinsubunitB(CTx-B)Alexa594-
conjugated, Click iT Metabolic Labeling Reagents for Proteins
Imaging Kit,β-galactosidase(β-gal)staining kit,1,10dioctadecyl-
3, 3,30,3 0-tetramethylindodicarbocyanine perchlorate (DiD),
3,30dioctadecyloxacarbocyanine perchlorate (DiO), ER-Tracker
Green (BODIPY FL glibenclamide), BODIPY FL C5-ceramide
(Golgi-Tracker), ProLong Gold antifading solution with DAPI
all purchased from Molecular Probes. Brefeldin A (BFA) was
purchased from Sigma-Aldrich.
Cell Culture and HIV-1 Infection
Experiments with human PBMC were performed in full
compliance with the ethical guidelines of the National Institutes
of Health and the University of Nebraska Medical Center.
Monocytes from HIV-1, 2 and hepatitis seronegative human
donors were obtained byleukophoresis, andpuriﬁedbycounter-
current centrifugal elutriation.
21 Human monocytes in suspen-
sion (Teﬂon ﬂasks) were cultured in DMEM (Invitrogen)
supplemented with 10% heat-inactivated human serum, 1%
glutamine, 10 μg/mL ciproﬂoxacin (Sigma-Aldrich), and 1000 U/mL
highly puriﬁed recombinant macrophage colony stimulating
factor (MCSF), a generous gift by Pﬁzer Inc., (Cambridge,
MA). Cells were allowed to diﬀerentiate to macrophages for 7 d
at 37 C in a 5% CO2. At day 7, MDM were exposed to the
macrophage-tropic strain HIV-1ADA at a multiplicity of infection
(MOI) of 0.5 infectious viral particles/cell for 24 h. Prior
to seeding in mixed cultures (infected and uninfected MDM),
HIV-1infectionwasassessedbyHIV-1p24immunostainingand
ﬂow cytometry.
Immunocytochemistry and Confocal Microscopy
All confocal imaging was performed in monocyte-derived
macrophages (MDM) mixed (1:1 uninfected and infected ratio)
cultures unless stated otherwise. MDM for imaging were grown
in poly D-lysine-coated LabTech (BD Biosciences) chamber
slides. Labeling of ER and Golgi in living cells was performed
using ER-Tracker Green (BODIPY FL glibenclamide) and
BODIPY FL C5-ceramide (Golgi-Tracker) per manufacturer’s
instructions. For retrograde tracing from early endosomes to
Goli-ER using CTx-B, cells were incubated with 100 mM CTx-B
in serum-free medium for 1 h. For disruption of endocytic
sorting, MDM were treated with 0.5 mM BFA for 3 h. Cells
from all applications we washed three times with warm PBS and
ﬁxed with 4% paraformaldehyde (PFA) pH 7.4 for 30 min at
room temperature. Cells were treated with blocking/permeabi-
lizingsolution(0.1%Triton,5%BSAinPBS)andquenchedwith
50 mM NH4Cl for 15 min. Cells were washed once with 0.1%
Triton in PBS and sequentially incubated with primary and
secondary Abs at room temperature. Unbound Abs were
removed by washing in blocking/permeabilizing solution and
PBS. Slides were covered in ProLong Gold antifading reagent
with DAPI and imaged using a 63  oil lens in a LSM 510
confocal microscope (Zeiss).
BC Isolation and Imaging
CellswereﬁrstmaintainedinTeﬂonﬂasksandmediachanged
every 2 d. Cells were centrifuged at 300g for 5 min and
resuspended(2 10
6cells/ml)withminimalpipetingingrowth
media then seeded on a 9 mm thick polycarbonate ﬁlter
(NeuroProbe) containing 3 μm in diameter pores separating
the upper and the lower wells of a one-well Boyden separation
chamber (NeuroProbe). BC were collected by exposing them to
the uninfected MDM-conditioned medium (lower well). Cell
suspensions were added to the upper well and the chamber was
placed in an enclosed humidiﬁer box and incubated at 37 C and
5%CO2tissuecultureincubatorfor4h.Conduitswereharvested
ineachﬁlterwhichwasimmersedin100%methanolfor15sthen
placed ﬁrmly with migrated cell materials down (attached to the
undersurfaceofﬁlters)onaglassslide.Cellswerewipedfromthe
ﬁlter top with Kimwipes and the ﬁlter was then gently peeled
oﬀ the slide with forceps. Processes were solubilized in lysis
buﬀer pH 8.5 [30 mM TrisCl, 7 M urea, 2 M thiourea, 4% (w/v)
3-(3-Cholamidopropyl) dimethylammonio)-1-Propanesulfonic
Acid (CHAPS), 20 mM dithiothreitol (DTT) and 1  protease
inhibitor cocktail (Sigma)] by pipeting. The remainder of the
lysate was allowed to crystallize on slides and harvested using
razor blades.
Scanning Electron Microscopy (SEM)
Infected MDM to be examined by SEM were seeded on a
polycarbonateﬁltermembraneof aBoyden chemotaxis chamber
for4htoallowformigrationoftheirprocessesthroughthepores.
Filter membrane was removed washed in PBS and ﬁxed in 2%
glutaraldehyde and 2% PFA in 0.1 M Sorensen’s phosphate
buﬀer. Samples were critical point dried, mounted on specimen
stubs, sputter- coated with 40 nm of gold/palladium and
observed with a FEI Quanta 200 SEM (Fei Company) operated
at 25 KV.
2D Electrophoresis and Mass Spectrometry
Following BC isolation, proteins were solubilized in lysis
buﬀer pH 8.5 [30 mM TrisCl], 7 M urea, 2 M thiourea, 4%
weight/volume (w/v) CHAPS and 1  protease inhibitor cock-
tail(Sigma)].Proteinswereprecipitatedusinga2DCleanupKit
and quantiﬁed by 2D Quant (GE Healthcare) per the manufac-
turer’s instructions. Samples underwent isoelectric focusing and
second dimension electrophoresis as described.
22 Proteins were
ﬁxedwith10%methanol,7%aceticacidfor24handstainedwith
SyproRuby at room temperature for 24 h. Spots were auto-
matically excised using an Ettan Spot Picker (GE Healthcare)
followed by in-gel tryptic digestion (10 ng/spot of trypsin3227 dx.doi.org/10.1021/pr200262q |J. Proteome Res. 2011, 10, 3225–3238
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Table 1
STRING ID
a protein ID
b peptides
c MW
d UniProt
e location
f function
g
CLTC Clathrin 17 191613 Q00610 PM/EV Endosome traﬃc
ATP6 V1A ATPase, Hþ transporting, isoform 1 3 68304 P38606 PM/EV Endosome traﬃc
AP1B1 Clathrin assembly protein complex 1 2 104606 Q10567 PM/EV/G Endosome traﬃc
COPA Xenin 2 138345 P53621 C/G Endosome traﬃc
TFRC CD71 antigen 4 84901 P02786 PM Endosome traﬃc
SNX2 Sorting nexin 2 4 58535 O60749 G/L Endosome traﬃc
SPG3A Atlastin-1 2 40451 Q8WXF7 G Endosome traﬃc
NA Erlin-1 6 38926 O75477 ER Endosome traﬃc
ADFP Adipophilin 2 48100 Q99541 PM Endosome traﬃc
FERL3 Myoferlin 3 234706 Q9NZM1 PM Endosome traﬃc
ATP6 V1B2 Vacuolar Hþ ATPase B2 (VATB2) 4 56500 P21281 PM/EV Endosome traﬃc
VAT1 Vesicle amine transport protein 1 3 41920 A8K345 PM/EV Endosome traﬃc
GDI2 GDP dissociation inhibitor 2 isoform 1 4 50663 Q6IAT1 EV Endosome traﬃc
RAB5C RAB5C, member RAS oncogene family isoform B 2 23482 P51148 EV Endosome traﬃc
M6PRBP1 Mannose 6 phosphate receptor binding protein 1 3 47047 O60664 EV/G Endosome traﬃc
PDCD6IP Programmed cell death 6-interacting protein 2 68292 Q8WUM4 EV Endosome traﬃc
COPZ1 Coatomer protein complex, subunit zeta 1 (COPZ) 2 20198 P61923 PM/EV/G Endosome traﬃc
CAPN8 M-Calpain Form I 2 79875 A6NHC0 G/C Endosome traﬃc
ARF5 ADP-ribosylation factor 5 2 20530 P84085 ER-G Endosome traﬃc
VCP Transitional endoplasmic reticulum ATPase 3 89321 P55072 ER Endosome traﬃc
MYH9 Nonmuscle myosin heavy polypeptide 9 19 226530 Q60FE2 CSK Endosome traﬃc
MYO1F Myosin-If 2 124803 O00160 CSK Endosome traﬃc
MYO9B Myosin-IXb 3 243555 Q13459 CSK Endosome traﬃc
MYH11 Myosin heavy chain 11 isoform SM1A 3 227337 B1PS43 CSK Endosome traﬃc
TPM4 Tropomyosin 4 5 28522 Q5U0D9 CSK Endosome traﬃc
ATG7 APG7 autophagy 7-like 2 77959 O95352 EV Autophagy
FCGR3B Fc Fragment (CD16b) 2 25205 O75015 PM/EV Phagocytosis
ANXA1 Annexin I 10 35040 P04083 EV/CSK Membrane fusion/Endocytosis
ANXA4 Annexin IV 2 36085 P09525 PM Membrane fusion/Endocytosis
PICALM PICALM variant protein 2 77396 Q4LE54 PM/EV Receptor-mediated endocytosis
ANXA2 Annexin A2 isoform 2 12 38604 P07355 S/EV Exocytosis
APOA1 Apolipoprotein A-I preproprotein 4 30778 P02647 S Cholesterol exocytosis
APOB48R Apolipoprotein B48 receptor (MBP200) 2 114835 Q0VD83 PM/EV Endocytosis of chilomicrometers
NA Glucose-regulated Homologue Precursor (GRP 78) 2 73696 Q5BBL8 ER Chaperone
PPIB Cyclophilin B 3 22742 P23284 ER Chaperone
ERO1L Oxidoreductin-1-Lalpha 2 54392 Q96HE7 ER Chaperone
HSPA5 Heat shock 70 kDa protein 5 9 72332 P11021 G/PM/ER Chaperone
HSPA9 Heat shock 70 kDa protein 9 precursor 6 73680 P38646 M/EV Chaperone
HSP90AA1 Heat shock protein HSP 90-alpha 3 84673 P07900 C/L Chaperone
HSP90AB1 Heat shock 90 kDa protein 1, beta 7 83264 P08238 C/EV Chaperone
NA ER-60 protease 9 56796 NA EV/ER Chaperone
CALR Calreticulin precursor 8 48141 P27797 C/ER/S Calcium-dependent chaperone
CANX Calnexin precursor 5 67568 P27824 ER Calcium-dependent chaperone
P4HB prolyl 4-hydroxylase, beta subunit precursor 6 57116 P07237 PM/ER/EV Protein agreggation
RPSA 40S ribosomal protein SA 3 33313 P08865 R Protein biosynthesis
RPL11 Ribosomal protein L11 2 20115 P62913 R Protein biosynthesis
RPS3 Ribosomal protein S3 4 26688 P23396 ER/PM Protein biosynthesis
ENSG00000185078 Ribosomal protein L9 2 21863 P32969 ER Protein biosynthesis
RPL12 Ribosomal protein L12 3 17818 P30050 R Protein biosynthesis
RPS7 Ribosomal protein S7 2 22127 P62081 R Protein biosynthesis
RPLP0 Ribosomal protein P0 2 9518 P05388 R Protein biosynthesis
RAN GTPase Ran 2 24423 P62826 EV/C Protein biosynthesis
CTSB Procathepsin B 3 35169 P07858 L/EV Protein metabolism
TPP1 Lysosomal pepstatin insensitive protease 2 61229 O14773 L/EV Protein metabolism3228 dx.doi.org/10.1021/pr200262q |J. Proteome Res. 2011, 10, 3225–3238
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(Promega) for 16 h at 37 C. Peptide extraction and puriﬁcation
μC18ZipTip(Millipore)wereperformedontheProprepProtein
Digestion and Mass Spec Preparation Systems (Genomic
Solutions). Extracted peptides were fractionated on microcapil-
lary RP-C18 column (NewObjectives) and sequenced using
ESI LC MS/MS system (ProteomeX System with LTQ-
Orbitrap mass spectrometer, Thermo Scientiﬁc) in a nanospray
conﬁguration. The acquired spectra were searched against the
NCBI.fasta protein database narrowed to a subset of human
proteins using Sequest search engine (BioWorks 3.1SR software
from Thermo Scientiﬁc). The TurboSEQUEST search para-
meters were set as follows: Threshold Dta generation at 10000,
Precursor Mass Tolerance for the Dta Generation at 1.4, Dta
Search, Peptide Tolerance at 1.5 and Fragment Ions Tolerance
at 1.00. Charge state was set on “Auto” Database nr.fasta was
retrieved from ftp.ncbi.nih.gov and used to create “in-house” an
indexed human.fasta.idx (keywords: Homo sapiens, human,
primate). Proteins with two or more unique peptide sequences
(p < 0.05) were considered highly conﬁdent. Functional con-
nectivity maps were generated using String 8.3 software at
http://string-db.org (Table 1). Metabolic labeling and detection
of newly synthesized proteins in MDM were performed using
Click-It AHA labeling kits per manufacturer’s instructions
(Invitrogen).MetaboliclabelingwithAHAwasextendedto24h.
Immunoisolation of Endocytic Compartments
For immunoisolation of Rab9 endosomes uninfected and
infected MDM were seeded in mixed cultures and allowed to
polarize (>90% of cell population connected by BC). Cells were
then washed three times with 1X PBS, scraped in TG buﬀer
Table 1. Continued
STRING ID
a protein ID
b peptides
c MW
d UniProt
e location
f function
g
RPN2 Ribophorin-2 2 69302 P04844 ER Glycosylation
RPN1 Ribophorin I precursor 2 68569 P04843 ER Glycosylation
GBE1 Glucan (1,4-alpha-), branching enzyme 1 3 80459 Q04446 G Glycosylation
DDOST Oligosaccharyl transferase 5 50711 P39656 ER Glycosylation
UGCGL1 UDP-glucose ceramide glucosyltransferase-like 1 3 174975 Q9NYU2 ER/G Glycosylation
CAT Catalase 6 56614 P04040 L Redox
PRDX1 Peroxiredoxin 1 2 22110 Q06830 EV Redox
PRDX5 Peroxiredoxin 5 precursor, isoform A 4 22026 P30044 L Redox
PDIA6 Protein disulﬁde isomerase-associated 6 3 48121 Q15084 ER/EV Redox
ACSL1 Acyl-CoA synthetase 3 77943 P33121 ER/EV/L Lipid metabolism
HSD17B4 Hydroxysteroid (17-beta) dehydrogenase 4 5 79686 P51659 L Lipid metabolism
CES1 Monocyte/macrophage serine esterase 3 62521 P23141 ER Lipid metabolism
ASAH1 Acylsphingosine deacylase 3 44649 Q13510 L Lipid metabolism
PLD3 Phospholipase D3 2 48771 Q8IV08 ER Lipid metabolism
PDX6 Peroxiredoxin 6 3 25035 P30041 L/EV Lipid metabolism
FASN Fatty acid synthase 2 24898 P49327 C/EV Lipid metabolism
PRKCSH Glucosidase 2 precursor 2 59296 P14314 ER Carbohydrate metabolism
GANAB Glucosidase II 6 106899 Q14697 ER/G/EV Carbohydrate metabolism
ENO1 Alpha-enolase 2 49477 P06733 C/PM Carbohydrate metabolism
IDH1 Isocitrate dehydrogenase 1 (NADPþ) 4 46659 O75874 C/L Carbohydrate metabolism
GAA Lysosomal alpha-glucosidase precursor 4 105337 P10253 L Carbohydrate metabolism
ANXA11 Annexin A11 4 54389 P50995 PM/EV Calcium signaling
ANXA6 Annexin VI isoform 1 8 75873 P08133 PM/EV CD21/Calcium regulation
C4A Complement C4-A precursor 3 192770 P0C0L4 S/EV Immune response
RTN4 Neurite outgrowth inhibitor 3 129940 Q9NQC3 ER/M Cellular survival
NA Envelop glycoprotein [HIV-1] 2 10128 A4UIK8 Envelope Viral entry
NA Envelope glycoprotein [HIV-1] 2 13716 B0LLQ6 Envelope Viral entry
NA Envelope glycoprotein [HIV-1] 1 9703 Q0GFQ6 Envelope Viral entry
NA gp160 protein [HIV-1] 1 18420 A1IUF5 Envelope Viral entry
NA Gag protein [HIV-1] 2 22279 A8V1T0 Capsid Viral replication
NA Gag protein [HIV-1] 2 25463 A9PPV3 Capsid Viral replication
NA Rev protein [HIV-1] 1 12096 Q1KWV0 Accesory Transcription regulation
NA Nef protein [HIV-1] 2 23435 A7YLR6 Accesory Viral traﬃc
NA HIV-1 enhancer binding protein 3 2 253818 N/A Accesory N/A
aSTRING database accession number (accessible at http://string-db.org/).
bProtein ID.
cNumber of unique signiﬁcant (P < 0.05) peptides identiﬁed
for each protein.
dTheoretical molecular mass for the primary translation product calculated from DNA sequences protein.
eAccession numbers for
UniProt (accessible at http://www.uniprot.org/).
fPostulated subcellular localization (accessible at http://locate.imb.uq.edu.au and http://www.
uniprot.org/) as follows: Plasma membrane (PM); secreted (S); endoplasmatic reticulum (ER); ribosomes (R); cytoskeleton (CSK); cytosol (C);
mitochondria(M);endocyticvesicle(EV);lysosomes(L);Golgi(G);HIV-1;notavailable(N/A,inthisgroupareincludedproteinswithnopostulated
localization).
gPostulated cellular function (accessible at http://www.uniprot.org/).3229 dx.doi.org/10.1021/pr200262q |J. Proteome Res. 2011, 10, 3225–3238
Journal of Proteome Research ARTICLE
(10 mM HEPES-KOH, pH 7.2, 250 mM sucrose, 1 mM EDTA,
and 1 mM Mg(OAc)2 and disrupted by 15 strokes in a dunce
homogenizer. Nuclei and unbroken cells were removed by
centrifugation at 800  g for 15 min at 4 C. Supernatant was
layered on a 20% sucrose cushion and centrifuged at 100000  g
for 1 h. The pellet was resuspended in PBS and incubated with
protein A/G paramagnetic beads (20 μL of slurry; Millipore)
conjugated to Rab9 and isotype control Abs (10 μg of Ab) for
12 h at 4 C. Endocytic compartments bound to beads were
collected following three washes with 1  PBS on a magnetic
separator (Invitrogen).
Infectivity of Rab9 Endosomes
The TZM-bl cells were cultured in high glucose Dulbecco’s
Modiﬁed Medium (DMEM) supplemented with 10% fetal
bovine serum (FBS), 100 units of penicillin and 100 μg/mL of
streptomycin. Cells were allowed to reach 70% conﬂuence then
detached by 25 mM Trypsin/EDTA for 5 min at 37 C. Cells
were then seeded onto 4 well poly-D-lysine LabTech chamber
slides for 2 d (40% conﬂuence). Protein A/G paramagnetic
beads-boundtoisotypecontrolandRab9Abswerereconstituted
in supplemented DMEM (20 μL of slurry/500 μL of medium/
well) and added to TZM-bl. Chamber slides were placed on a
plate magnet for 24 h at 37 C and 5% CO2. Untreated, HIV-1-
exposed and isotype Ab-exposed TZM-bl were used as controls.
Cells were maintained in culture medium for additional 48 h
prior to β-gal detection using β-gal staining kit (per manufac-
turer’s instructions). Bright ﬁeld images were acquired using a
Nikon Eclipse TE300 microscope (Nikon).
Quantification of Confocal Microscopy and Statistical
Analyses
QuantiﬁcationofimmunostainingwasperformedwithImageJ
software, utilizing JACoP plugins (http://rsb.info.nih.gov/ij/
plugins/track/jacop.html) to calculate Pearson’s colocaliza-
tion coeﬃcients. Comparison was performed on 7 10 sets of
images acquired with the same optical settings. Endosome size
(diameter)wasmeasuredmanuallyusingLSM-Browsersoftware
(Zeiss). Scatter plots and bar graphs were generated using Prism
(GraphPadSoftwareInc.).One-tailedStudent’st-testswereused
for all data and the error bars are shown as standard error of the
mean (S.E.M.) unless noted otherwise.
’RESULTS
HIV-1 Infection Increases BC Formation
To assess whether HIV-1 infection aﬀects BC formation,
BC connected cells were counted at 3 h in adherent single
(uninfectedorinfected alone)ormixedcultures(uninfectedand
infected MDM at 1:1 ratio). BC frequency was increased in
infected and mixed cultures compared to uninfected MDM in
single culture (Figure 1A). Infected MDM in single and mixed
cultures acquired elongated morphologies and formed BC that
extended>100μm(Figure 1B). Singlecultureuninfected MDM
showed round ruﬄed appearances. However when these cells
weremixedwithvirus-infectedMDMat1:1ratiouninfectedcells
were established BC contacts (Figure 1C, D). These data
demonstrate that BC formation parallels HIV-1 infection.
Endosome, Golgi and ER Proteins Are Identified in the BC
Proteome
To determine the composition of the BC, we characterized its
proteome. HIV-1-infected MDM were seeded on a ﬁlter mem-
brane separating a Boyden chemotaxis apparatus into an upper
andalowerchamber.Cellswereallowedtopolarizebyextending
their processes through the 3-μm pores toward the conditioned
medium from uninfected MDM (lower chamber, Figure 2A).
SEM was performed to monitor cell polarization and migration
Figure 1. HIV-1 infection increases the frequency of BC formation
between uninfected and infected cells. (A) MDM connected by BC in
single (uninfected or infected) or mixed (uninfected and infected at
equal ratios) cultures at 180 min in adherence (*P < 0.05; **P < 0.001;
n = 250 cells/group, error bars þ S.E.M). (B) Bright ﬁeld image of
MDM connecting by BC in mixed culture. Arrows indicate three long
(>100 μm) tubular BC emanating from a single MDM toward neigh-
boringcells (scalebar, 20μm). (C) Uninfected MDMlabeled withDiO
lipophilic dye (green) in single culture. Note lack of cell polarity (BC)
and direct cell-to-cell contact. (D, E) Confocal images (including
diﬀerential interference contrast, DIC images) of uninfected (DiO-
labeled, green) and infected (DiD-labeled, red) MDM in mixed culture.
Arrows indicate BC connecting uninfected with uninfected cells. Note
both uninfected and infected MDM are capable of generating BC in
mixed culture (scale bar, 10 μm).3230 dx.doi.org/10.1021/pr200262q |J. Proteome Res. 2011, 10, 3225–3238
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of cellular protrusions through the pores (Figure 2B). Such BC
extensions were detached from cell bodies (Figure 2C) and
collected from cells derived from ﬁve independent experiments.
The BC were pooled and the solubilized proteins separated
by2Delectrophoresis.Theseareshown inrepresentativeimages
of 4 20% gradient 2D gels (Figure 2D). An average of 1100
spots were detected using DeCyder software and 275 proteins
identiﬁedbymassspectrometryathighconﬁdence(pe0.05and
2 or more unique peptides; Table 1 and S1, Supporting Infor-
mation). Ingenuity Pathway Analysis (IPA) separated the BC
proteome into 3 major functional groups. These included cel-
lular morphology and migration (actin cytoskeleton, cell
adhesion and motion, leukocyte extravasation, tight junction
and calcium signaling; Antigen and HIV-1 endocytic processing
Figure 2. Isolation and proteome characterization of macrophage BC. (A) Schematic of experimental design for BC isolation and proteomic analysis.
(B) SEM image of a human macrophage cultured on the upper chamber of a Boyden chemotaxis apparatus, extending its processes through the porous
membrane.(C)ConfocalimageofBCadheredtoglassslidepostdetachmentfromcellbodies,immunostainedformicrotubuleswithR/βtubulin-Alexa
488 Ab (ﬂuorescent green, pseudocolored white). (D) Representative image of 2D electrophoresis of BC lysate pooled from ﬁve independent cultures
(donors). Image of gel stained with deep purple dye. (E) Classiﬁcation of proteins identiﬁed in isolated BC by subcellular location. Only proteins
identiﬁed by 2 or more unique peptides were included in the analysis. Bold font indicates groups of interest. (Refer to Table 1 and S1, Supporting
Information, for protein ID).3231 dx.doi.org/10.1021/pr200262q |J. Proteome Res. 2011, 10, 3225–3238
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(caveole-, clathrin-, and Fc-dependent endocytosis, mechanisms of
HIV-1 endocytic entry and exit, micropinocytosis); Metabolomic
factors (carbohydrate, protein and fatty acid synthesis). Functional
connectivity analysis using protein interaction networks (http://
www.STRING-db.org)revealedhighlevelsofinteractionamong
these clusters as shown by bold lines in the connectivity map
(Figure S1A, Supporting Information).
23 Interestingly, removal
of highly abundant cytosolic and nuclear proteins residing in the
cell body, uncovered low abundance proteins that were not
identiﬁed inthe wholecelland membrane preparations.
22 More-
over, proteomic analysis comparisons between uninfected and
uninfected MDM BC showed no majordiﬀerences inprotein ID
(data not shown). Seventy-nine proteins (30% of the overall
proteome were organelles) were 3% were HIV-1 components.
The organelle markers included endolysosomal compartments
(14%), ER (9%) and Golgi (4%; Figure 2E). The excised spots
corresponding to these proteins are shown in Figure 4A and
Table 1. Further functional subclassiﬁcation and connectivity
analysis of endocytic, ER and Golgi proteins showed that
major protein clusters interact as regulators of post-translational
modiﬁcations such as N-glycosylation, protein folding, viral/
antigen endocytic uptake and release and cell-to-cell commu-
nication (Figure 4B D). The data show that the ER and Golgi
are in the conduits and support their roles in viral/antigen
processing.
HIV-1, Golgi and ER Proteins Are Identified in BC
Confocal microscopy was used to conﬁrm the presence of
Golgi and ER in BC. MDM were immunostained for giantin
(Golgi vesicle and membrane integral protein) and calnexin
(ER membrane protein). In nonpolarized cells ER and Golgi
were located in the perinulcear region and displayed known
ruﬄedandstackedmorphologies (Figure5A,arrows).Images of
BC-connected or polarized MDM showed ER distributed
throughout the conduit. In contrast, the Golgi network acquired
tubular morphologies (Figure 5A, B; inset boxes 1 and 2).
Interestingly, a single Golgi was observed between two con-
nected cells (Figure 5B, yellow arrows). BC-associated viral
proteins were seen within the ER and Golgi. Confocal imaging
showed Gag
þ and Env
þ compartments in BC that colocalized
with giantin and calnexin (Figure 5A, B). Env and Gag were also
observed in1.6μm calnexin
þand1.2 μm(in diameter)giantin
þ
endocytic vesicles in conduits (Figure 5C). Quantitation of
ﬂuorescence overlap using Pearson’s colocalization tests indi-
cated 72 and 32% of Env colocalized with ER and Golgi re-
spectively (Figure 5D). Gag distribution with calnexin and
giantin was measured at 50 and 22% respectively (Figure 5E).
Endocytosed HIV-1 is Transported to Golgi and ER
Having observed that HIV-1 Env and Gag are within the BC
and are associated with the ER and Golgi, we next investigated
whether these were newly synthesized viral proteins or shuttled
to these organelles. To explore associations between newly
synthesized viral proteins and the ER and Golgi, MDM were
metabolically labeled with azidohomoalanine (AHA; a methio-
nine substitute) in methionine-depleted medium. AHA incor-
poration into protein synthesized de novo was detected using
azide alkynecouplingreactionswithAlexa-647(alkyne).MDM
were also immunostained for HIV-1 Env and Gag. Maximum
overlap of viral and metabolically labeled proteins was observed
at the plasma membrane (likely reﬂecting processes of progeny
assembly) but not the conduits (Figure 6A, B; inset boxes 1 and 2).
Furthermore, minimal distribution of metabolically labeled pro-
tein with Golgi was observed suggesting Env and Gag distribut-
ingwiththeseorganellesmaybeofendocyticorigin(Figure6C).
Live tracking of ﬂuorescently labeled HIV-1 (DiO) with ER/
Golgi (ER- and Golgi-tracker dyes) revealed accumulation of
HIV-1 in ER and Golgi tubules extending into the conduits
(Figure 6D, arrows). These ﬁndings demonstrate that seques-
tered HIV-1 is shuttled to the ER and Golgi.
HIV-1 Env and Gag Undergo Retrograde Transport to the
Trans-Golgi
Next, we investigated the pathways for HIV-1 Env and Gag
traﬃcking to the Golgi network. Following endocytosis at the
plasma membrane proteins destined for Golgi can undergo
retrograde sorting routes from early/recycling endosomes and
late endosomes to the Golginetwork.
24 Among the organelles of
thesecretory/recyclingpathwayTrans-Golgihasacentralroleas
a site of protein sorting.
24 Once proteins reach Trans-Golgi they
face several sorting destinations: the extracellular space, diﬀerent
domains of the plasma membrane, and Rab11 recycling
endosomes.
24 Therefore we questioned whether HIV-1 Env
and Gag can undergo retrograde transport from early/recycling
endosomes to the Golgi network. Co-distirbution of Env and
Gag with ﬂuorescently labeled cholera toxin subunit B (CTx-B)
was tested, since CTx-B has been previously documented to
Figure 3. Major biological functions relevant to viralendocytic processing (including post-translational modiﬁcation) and cytoskeletal rearrangements
in BC. (A) Classiﬁcation by function of BC proteome based on higher statistical signiﬁcance of protein groups [ log (P value); threshold set at 1.3].
Graphs were generated using Ingenuity Pathway Analysis (IPA) software.3232 dx.doi.org/10.1021/pr200262q |J. Proteome Res. 2011, 10, 3225–3238
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undergo retrograde sorting from early/recycling-endosomes to
the Golgi.
25 MDM in mixed culture were exposed to the CTx-
B-Alexa594andthenstainedforEnvandGag.Env
þ/B-CTx
þand
Gag
þ/B-CTx
þ compartments were observed in BC (Figure 7A, B).
Env and Gag colocalizations with B-CTx were measured at 39 and
41%,respectively(Figure7C).Thesedatasuggestedthataportionof
the viral protein pool undergoes parallel sorting to CTx-B.
In addition to retrograde transport from early endosome to
Golgi, a crucial step in the HIV-1 replication cycle is Rab9-
mediated retrograde sorting to the Trans-Golgi.
16 18 Gene
silencing of Rab9 and other host factors (TIP47, p40) that
regulate late endosome to Trans-Golgi transport blocks HIV-1
replication.
16 Since ﬂuorescently labeled HIV-1 was detected in
the ER and Golgi tubules, we tested the virulence of HIV-1
sequestered into Rab9 endosomes and its distribution with the
Trans-Golgi.ConfocalimagingshowedEnvandGagdistribution
with in Rab9
þ vesicles and TGN38
þ (Trans-Golgi membrane
protein) in the conduits (Figure 7D, F). Colocalization assays
showed a 19 and 30% overlap of Env with Rab9 and TGN38
compartments. Eighteen and 24% of Gag overlapped with Rab9
and TGN38 (Figure 7E, G).
To test if HIV-1 present in Rab9 endosomes were infectious,
BC compartments were isolated by immunoaﬃnity chromato-
graphy. Protein A/G paramagnetic microbeads conjugated to
Rab9 or isotype Abs (used as control of binding speciﬁcity) were
incubated with homogenized cell lysate clariﬁed from cellular
debris(plasmamembraneandnuclei)andcollectedbymagnetic
separation. Endocytic compartments bound to paramagnetic
beads were then introduced to the TZM-bl cells using a magnet
plate. The TZM-bl reporter cell line expressed ss-gal under the
control of the HIV-1 promoter. At 72 h postexposure ss-gal
(blue) was detected as a measure of HIV-1 gene integration and
expression. Bright ﬁeld images in Figure 8A show ss-gal expres-
sion (blue) in TZM-bl exposed to free HIV-1 (positive control)
and Rab9 endosomes (arrows). Quantitation of blue cells
revealed that the contents of Rab9 endosomes were infectious
Figure 4. Identiﬁcation of ER, Golgi and endosome proteins and their functional relevance in viral traﬃc through BC. (A) Representative 2D
electrophoresisofBClysate.IsolatedBCfromﬁveseparateculturesand500μgofpooledprecipitatedproteinwasappliedtoapHgradient(3 10)strip
and separated on the ﬁrst dimension by isoelectric focusing. The strip was loaded into a large format gradient gel (4 20%) for second dimension
separation of BC proteins. Gel was ﬁxed and poststained with deep purple dye for positive detection of proteins spots. Encircled protein spots
correspond to ER (red), Golgi (green), endosome (black) and HIV-1 (green) subproteome identiﬁed by nano-LC MS/MS. (B, C) IPA classiﬁcation
by biological and canonical function of ER, Golgi, endosome proteins with signiﬁcant relevance [ log (P value)] to HIV-1 BC traﬃcking. For
classiﬁcationbybiologicalfunctiononlyproteinsabovethesetthreshold(1.3)weregroupedforanalysis.(D)ConnectivitymapoftheBCsubproteome
displaying functional interaction between ER, Golgi, endosome and HIV-1 proteins. Line thickness indicates level (conﬁdence) of interaction. Protein
IDs corresponding to abbreviations used in the connectivity map are included in Table 1 and S1, Supporting Information.3233 dx.doi.org/10.1021/pr200262q |J. Proteome Res. 2011, 10, 3225–3238
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(Figure 8B). Together these data indicate that HIV-1 destined
for intercellular transfer undergoes retrograde sorting from early
and late endosomes to the Trans-Golgi.
Disruptionof ER-Golgi NetworksBlocks Conduit HIV-1 Transport
Next we questioned whether disruption of recycling and the
ER-Golgi network would aﬀect transfer of HIV-1 through the
conduits. Incubation of cells with fungal metabolite BFA was
found to inhibit ER-to-Golgi transport, resulting in the rapid
redistribution of Golgi markers into the ER, collapsed Trans-
Golgi and impair of Rab11-mediated recycling.
26 Exposure of
polarized MDM to 0.5 mM of BFA resulted in the accumulation
of Env and Gag in large TGN38
þ compartments (Figure 8C, D;
arrows). More importantly, presence of Env
þ and Gag
þ vesicles
Figure5. DistinctmorphologiesofERandGolgiinBC-connectedcellsandtheirpresencewithintheconduits.(AandB)ConfocalimagesofMDMin
mixed culture connected by BC. Immunostaining for giantin (Golgi, green) and calnexin (ER, purple) demonstrates organelle tubular morphologies
and their codistribution with HIV-1 Env (red) and Gag (red) within the conduits (inset box 1, 2). Arrows in panel B indicate a single tubular
Golgi equidistant from two connected cells (scale bars, 10 μm; inset boxes, 5 μm). (C) Size distribution of Gag and Env endocytic vesicles carrying ER
(n=35vesicles)andGolgi(n=28vesicles)markersintheBC(errorbars(S.E.M).(D,E)QuantitativedistributionofviralproteinswithERandGolgi.
Pearson’s colocalization coeﬃcients indicate percent overlap of Env and Gag with calnexin and giantin (error bars ( S.E.M; n = 80 cells).3234 dx.doi.org/10.1021/pr200262q |J. Proteome Res. 2011, 10, 3225–3238
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intheBCwasdiminished.Thesedatasuggestthatintegrityofthe
ERandGolgi-Trans-Golginetworksisnecessaryforviralprotein
traﬃcking through the BC.
’DISCUSSION
Employing functional proteomics and imaging assays we
characterized themacrophageconduitsandelucidatedendocytic
pathways that eﬀect HIV-1 intercellular traﬃcking through BC.
Together with previous studies
11,13,17 we show that following
clathrin-dependentendocytosis,HIV-1issequesteredintoearlyand
late endosomes and “hitchhikes” retrograde sorting pathways to
reach the ER and Golgi. Virus uses these organelles as a sorting
station for HIV-1 prior to intercellular transfer. In parallel, HIV-1
induces cytoskeletal alterations enhancing the formation of a BC
network.
32 The mechanisms of BC formation is incompletely
understood. In T cells and MDM these protrusions are established
asadjacentcellspullawayfromeach-otherfollowingbriefcontactor
bygenerationoftheprotrusionfromonecelltoanother.
1,6Sincean
increaseinBCwasobservedinMDMmixedcultures.Itislikelythat
the stimuli for BC formation originates primarily by infected cells.
This may be due to an increase in the metabolic and secretory
activities associated with viral infection.
9
Figure 6. HIV-1 Env and Gag targeted to Golgi are of endocytic origin. MDM in mixed culture were labeled by metabolic incorporation of 50 μMo f
azidohomoalanine (AHA) into newly synthesized proteins for 24 h using methionine-free medium. Cells were ﬁxed and AHA-labeled proteins were
detectedusingalkyneAlexa-647.(A,B)ConfocalimagingofmetabolicallylabeledMDMimmunostainedforHIV-1EnvandGagshowoverlapofthese
viral constituents with newly synthesized proteins at the plasma membrane but not BC. (C) Co-immunostaining with giantin shows minimal distribu-
tion of AHA-labeled proteins with the Golgi tubule. (D) Sequestration of endocytosed ﬂuorescently labeled HIV-1 (DiD dye, red) into Golgi and ER
(Golgi- and ER-tracker dyes, green). MDM in mixed culture were ﬁrst labeled with a combination of BODIPY FL glibenclamide (ER-tracker) and
BODIPY FL C5-ceramide (Golgi-tracker) for 1 h then exposed HIV-1-DiD for 1 h. Excess dye and noninternalized HIV-1 were removed by washing
and cells were observed by time-lapse confocal imaging. Arrows indicate distribution of endocytosed HIV-1 with ER-Golgi tubules in polarized MDM
(scale bars, 10 μm; inset boxes, 5 μm).3235 dx.doi.org/10.1021/pr200262q |J. Proteome Res. 2011, 10, 3225–3238
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The ER and Golgi networks commonly located in the peri-
nuclear region of cells extend within the conduits in polarized
MDM. What causes these to acquire such unique morphologies
may be due to rearrangements of cytoskeletal and endocytic
networks required for the formation and function of bridging
conduits.MacrophageBCarethickandelongatedstructuresthat
contain dense networks of microtubules. It is likely that during
conduit formation microtubule bundling may also lead to
rearrangement from Golgi and ER stacks to tubules. Alterna-
tively, Golgi and ER may traﬃc between cells through conduits
Figure 7. HIV-1 Env and Gag undergo retrograde transport from early and late endosomes to the ER-Golgi. (A-C) Env and Gag endocytic sorting
parallels that of cholera toxin subunit b (CTx-B). MDM in mixed culture were exposed to CTx-B-Alexa 594 conjugated (red). Cells were ﬁxed and
immunostained for Env (green) and Gag (green) and imaged by confocal microscopy. Inset boxes show at a higher magniﬁcation BC-associated
endocytic compartments transporting CTx-B, Env and Gag. Pearson’s colocalization coeﬃcients are indicated as percent overlap of CTx-B with Env
and Gag. (D, E, G) Distribution of Env and Gag with Rab9 late endosomes and the Trans-Golgi along the BC. MDM in mixed culture were
immunostained for Env (red), Gag (red), TGN38 (Trans-Golgi marker, green) and Rab9 (late endosomes, purple). Distribution by size (diameter) of
Rab9 and TGN38 compartments positive for Env and Gag (n = 65 endocytic compartments/group, error bars ( S.E.M). Confocal images of MDM
showing colocalization of Env and Gag with Rab9
þ and TGN38
þ compartments in the BC (inset boxes 1; scale bar, 10 μm). (F, H) Quantitation of
colocalization (ﬂuorescence overlap) of Env and Gag with Rab9 and TGN38 compartments in the BC (n = 80 cells/group, error bars ( S.E.M).3236 dx.doi.org/10.1021/pr200262q |J. Proteome Res. 2011, 10, 3225–3238
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similar to mitochondria and lysosomes and their distribution
within the BC may accelerate communication between con-
nected cells.
1,2 Indeed, ER and Golgi cellular distribution and
morphologies have been linked to the dynamics of microtubule
rearrangements. These organelles attach to the growing plus end
of the microtubules and travel on these tracks to divergent
cellular locations.
27 29
The function of ER and Golgi in relation to BC will need further
investigation.Wepositthatinadditiontosustainingorganelletravel
between cells, conduits may accelerate intercellular exchange by
Figure 8. Rab9 endosomes carry infectious particles and disruption of ER-Golgi impairs HIV-1 transfer through the conduits. (A) Rab9 endosomes
wereisolatedbymagneticseparationfrommechanicallyrupturedpolarizedMDMusingproteinA/GparamagneticbeadsconjugatedtoRab9Ab.Bead-
captured endosomes were washed and were forced into TZM-bl reporter cell line by subjecting the cells to magnetic ﬁelds. HIV-1 genome integration
and expression in TZM-bl was measured at 72 h postexposure in the form of ss-gal production (blue). Representative bright ﬁeld images of uninfected
TZM-bl (negative control), cells exposed to beads conjugated to isotype Ab (control for speciﬁcity of binding), cell-free HIV-1 (positive control) and
Rab9 immune-isolated endosomes at 72 h postexposure. Arrows indicate paramagnetic beads (brown) within TZM-bl. (B) Quantiation of overall
endosomeinfectivityinTZM-bl(scalebars100μm;errorbars,(S.E.M.,n=400cells/group,N=2independentexperiments).(C,D)Confocalimages
of MDM connected by BC in mixed culture treated with fungal metabolite BFA and immunostained for HIV-1 Env and Gag. Arrows indicate
accumulation of viral proteins in large vacuoles in the cell body (scale bar, 10 μm; inset boxes, 5 μm).3237 dx.doi.org/10.1021/pr200262q |J. Proteome Res. 2011, 10, 3225–3238
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acting as sites of mRNA translation and protein synthesis. This may
be similar to processes observed in the axon where synthesis and
incorporation of neurotransmitters into presynaptic vesicles occurs
in proximity of the synapse.
30 This kind of Golgi/ER rearrange-
mentsmayaccelerateHIV-1intercellularspreadasviralgenomecan
be expressed in proximity to the uninfected target cell, rather than
expressed in the cell body and then transported to the uninfected
cell. Elongation and translation factors, transporters of mRNA, and
cellular and viral RNA were identiﬁed in the BC (our unpublished
observations).
31 Furthermore, presence of enzymes regulating
protein, carbohydrate, lipid and metabolism further support the
role of BC as metabolically active structures.
We have previously demonstrated that formation of the con-
duits precedes syncytium formation in HIV-1 infected MDM.
32
Therefore, ERand Golgi extending withinthe conduits arelikely
to be shared by the connected cells functioning as a unicellular
entity. Indeed, in the current study we often observed single
Golgi tubules located halfway within the conduit between two
cells.Inmultinucleatedgiantcellscentralaccumulationofseveral
Golgi tubules surrounded by more than 50 nuclei and then ER
was observed.
What drives transport of HIV-1 to the Golgi network and ER
and more importantly how does this aﬀect targeting of the viral
constituents to their ﬁnal destination (i.e., BC intercellular
transfer) remain open questions. The need for post-translational
processing may target viral constituents to ER and Golgi. These
inturncanalsobeusedasaddresscodessendingviralproteinsto
speciﬁc subcellular locations or BC for intercellular transfer.
Proper folding and Glycosylation of envelope proteins is an
important evolutionary process that impacts viral infectivity
and selection.
33 Indeed, mutations in the glycan shield of HIV-1
may account in part for viral immune evasion persistence to
neutralizing antibodies.
34 HIV-1 gp120 undergoes heavy O- and
N-glycosylation and mannose trimming in the ER-Golgi net-
work.O-linkedcarbohydratesareattachedtothehydroxylgroup
of serines and threonines residues of HIV-1 Env after transport
to Golgi.
35 Gag may also be targeted to the ER following
monoubiquitination, as a quality control measure.
36 Ubiquitina-
tion seems to be responsible for viral budding within endocytic
compartments such as MVB as well as gag maturation and
infectivity.
37 Regulators of the ubiquitin-proteosome pathway
were readily identiﬁed in the BC proteome and it is likely that
such processes may also drive intercellular transfer of active viral
constituents.
SortingofviralconstituentsthroughERandGolgimayalsobe
a survival mechanism HIV-1 adopts during infection-induced
apoptosis or necrosis. At this time the virus survives by utilizing
any available cellular membranes (plasma and organelle) for its
assembly. Indeed, previous ultrastructural studies have shown
HIV-1 progeny assembling on Golgi and ER membranes at the
late stages of macrophage infection.
19,20 Interestingly, recent
studies have shown that immune cells such as natural killers
(NK) use bridging conduits to transfer apoptosomes and other
packed cellular fragments from a dying to healthy cells.
38 We
have also often observed establishment of contact between
multinucleated giant cells and single polarized macrophages at
the late stages of infection (our unpublished observations).
Similar to NK conduits, macrophage BC may also have debris-
clearing functions. As such, it is likely that presence of viral
proteins in ER and Golgi compartments along the conduits may
reﬂecttheabilityofHIV-1tosurvivedeathofthehostandusethe
BC-mediated debris clearing activity to accelerate infection.
At the early stages of infection associated with minimal cell
death sorting of HIV-1 constituents through ER and Golgi can
also be explained by BC-mediated antigen presentation. It has
been recently documented that antigen-presenting cells use BC
in vivo to accelerate antigen presentation.
5,10 We have previously
detected major histocompatibility complex class II (MHC II)
HLA-DR in Rab11 endosomes and MVB transporting HIV-1
constituentsthroughthemacrophageconduits(ourunpublished
observations). HLA-DR endocytic processing appears similar to
HIV-1 as both undergo internalization and sorting through early
endosomes to recycling endosomes and subsequently ER, cis-
andtrans-Golgi(ourunpublishedobservations).
39Thereforeitis
likely that a portion of the viral constituents parallels HLA-DR
intra- and intercellular traﬃc. This would explain the dual role of
BFA in disrupting HIV-1 transport through the conduits and
antigen presentation.
39
’CONCLUSION
Using proteomic and imaging technologies new insights into
how HIV-1 uses basic immune cell functions to its advantage
was explored. The virus “hitchhikes” from cell-to-cell using BC
cytoskeletal andendocyticmachineries toaccelerateviralspread.
Such mechanisms are likely relevant for preventative vaccination
strategies as they proves a means for the virus to evade immune
surveillance.
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